Affiliation:
1. Departments of Pathology Baptist Hospital of Miami and Miami Cancer Institute Miami Florida USA
2. Department of Pathology Massachusetts General Hospital Boston Massachusetts USA
Abstract
AbstractThe risks of malignancy for cytologic categories in renal biopsy specimens differ from the risks in most other sites. There are obvious areas in which cytopathologists can do better at classifying these cases, and the routine use of immunohistochemistry and core‐needle biopsy may improve the accuracy of the classification of these specimens.